VRTX:NGS-Vertex Pharmaceuticals Incorporated (USD)

EQUITY | Biotechnology | Nasdaq Global Select

Last Closing

USD 495.72

Change

-6.88 (-1.37)%

Market Cap

USD 21.38B

Volume

1.35M

Analyst Target

USD 306.43
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-31 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
REGN Regeneron Pharmaceuticals Inc

N/A

USD 130.01B
ARGX argenx NV ADR

N/A

USD 32.41B
ALNY Alnylam Pharmaceuticals Inc

N/A

USD 32.27B
MRNA Moderna Inc

N/A

USD 28.23B
BGNE BeiGene Ltd

N/A

USD 20.54B
BMRN Biomarin Pharmaceutical Inc

N/A

USD 17.44B
RPRX Royalty Pharma Plc

N/A

USD 17.14B
UTHR United Therapeutics Corporatio..

N/A

USD 15.72B
INSM Insmed Inc

N/A

USD 12.93B
SRPT Sarepta Therapeutics Inc

N/A

USD 12.85B

ETFs Containing VRTX

DCCHAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

N/A

USD 0.07B
DCUSAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

N/A

N/A
DCEUAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

N/A

N/A
DCGBAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

N/A

N/A
MSGR 8.22 % 0.00 %

N/A

N/A
CURG:LSE VanEck Genomics and Healt.. 8.05 % 0.00 %

N/A

USD 6.97M
CURE:XETRA VanEck Genomics and Healt.. 7.99 % 0.00 %

N/A

N/A
BTEC:SW iShares Nasdaq US Biotech.. 7.95 % 0.00 %

N/A

N/A
UBIO 6.52 % 0.95 %

N/A

N/A
LIFE-B:CA Evolve Global Healthcare .. 5.49 % 0.00 %

N/A

N/A
ZWHC:CA BMO Covered Call Health C.. 5.16 % 0.00 %

N/A

N/A
LIFE:CA Evolve Global Healthcare .. 5.00 % 0.69 %

N/A

CAD 0.22B
LIFE-U:CA Evolve Global Healthcare .. 5.00 % 0.00 %

N/A

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.94 % 0.00 %

N/A

N/A
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.91 % 0.00 %

N/A

N/A
XNNS:LSE Xtrackers MSCI Innovation.. 4.83 % 0.00 %

N/A

N/A
XNNV:LSE Xtrackers MSCI Innovation.. 4.83 % 0.00 %

N/A

N/A
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.77 % 0.00 %

N/A

USD 0.15B
XNNV:XETRA Xtrackers MSCI Innovation.. 4.76 % 0.00 %

N/A

N/A
SAMM The Advisors’ Inner .. 4.15 % 0.00 %

N/A

N/A
XDGI:XETRA Xtrackers MSCI Global SDG.. 3.70 % 0.00 %

N/A

USD 0.02B
HEAL:CA 3.39 % 0.00 %

N/A

N/A
CDNA:CA 3.01 % 0.00 %

N/A

N/A
BIOT:SW L&G Pharma Breakthrough U.. 2.68 % 0.00 %

N/A

N/A
CURE:AU ETFS S&P Biotech ETF 2.59 % 0.00 %

N/A

USD 0.04B
DRUP GraniteShares ETF Trust -.. 2.50 % 0.00 %

N/A

USD 0.06B
HLTH:AU VanEck Global Healthcare .. 2.46 % 0.00 %

N/A

USD 0.06B
UPWD 2.43 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 2.32 % 0.00 %

N/A

CAD 0.09B
POWA Invesco Bloomberg Pricing.. 2.11 % 0.00 %

N/A

N/A
XLVE:CA Mulvihill U.S. Health Car.. 1.93 % 0.00 %

N/A

N/A
ZUH:CA BMO Equal Weight US Healt.. 1.74 % 0.39 %

N/A

CAD 0.28B
MVEA:SW iShares Edge MSCI USA Min.. 1.62 % 0.00 %

N/A

USD 0.38B
ESMV iShares ESG MSCI USA Min .. 1.56 % 0.00 %

N/A

USD 0.01B
MVEC:SW iShares Edge MSCI World M.. 1.42 % 0.00 %

N/A

USD 0.17B
MVEW:SW iShares Edge MSCI World M.. 1.42 % 0.00 %

N/A

USD 0.60B
MVWE:SW iShares Edge MSCI World M.. 1.42 % 0.00 %

N/A

USD 0.07B
MVEW:LSE iShares Edge MSCI World M.. 1.37 % 0.00 %

N/A

USD 0.60B
WEBA:XETRA Amundi US Tech 100 Equal .. 1.22 % 0.00 %

N/A

USD 0.60B
FLXU:SW Franklin U.S. Equity UCIT.. 1.17 % 0.00 %

N/A

N/A
THNZ:XETRA L&G Global Thematic ESG E.. 1.03 % 0.00 %

N/A

N/A
BBH VanEck Biotech ETF 0.00 % 0.35 %

N/A

USD 0.45B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

N/A

USD 0.09B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

N/A

USD 3.31M
DEF 0.00 % 0.59 %

N/A

N/A
FBT First Trust NYSE Arca Bio.. 0.00 % 0.57 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

N/A

USD 7.71B
LABD Direxion Daily S&P Biotec.. 0.00 % 1.00 %

N/A

USD 0.10B
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

N/A

N/A
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

N/A

USD 0.02B
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BIGT:LSE L&G Pharma Breakthrough U.. 0.00 % 0.00 %

N/A

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
VLQ:CA 0.00 % 0.40 %

N/A

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

N/A

N/A
ZBIO 0.00 % 0.95 %

N/A

N/A
HWWA:LSE HSBC Multi Factor Worldwi.. 0.00 % 0.00 %

N/A

N/A
SMRG:LSE 0.00 % 0.00 %

N/A

N/A
SMRU:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
HWWD:LSE HSBC Multi Factor Worldwi.. 0.00 % 0.00 %

N/A

N/A
VMOM:LSE 0.00 % 0.00 %

N/A

N/A
SMRT:PA 0.00 % 0.00 %

N/A

N/A
2B70:F iShares NASDAQ US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
ETLI:F Legal & General UCITS ETF.. 0.00 % 0.00 %

N/A

N/A
FLXU:F Franklin LibertyShares IC.. 0.00 % 0.00 %

N/A

N/A
SM8T:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
2B70:XETRA iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
ETLI:XETRA L&G Pharma Breakthrough U.. 0.00 % 0.00 %

N/A

USD 0.02B
FLXU:XETRA Franklin LibertyShares IC.. 0.00 % 0.00 %

N/A

USD 0.18B
SM8T:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.04B
TGGR:CA TD Active Global Equity G.. 0.00 % 0.00 %

N/A

CAD 0.04B
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
ZINN:CA 0.00 % 0.00 %

N/A

N/A
MVEW:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

USD 0.78B
NVQ 0.00 % 0.00 %

N/A

N/A
SMRU:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 3.48M
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

N/A

USD 1.13B
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

N/A

USD 0.04B
NDOW 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.83% 73% C 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.83% 73% C 81% B-
Trailing 12 Months  
Capital Gain 38.31% 78% C+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.31% 78% C+ 86% B+
Trailing 5 Years  
Capital Gain 177.89% 87% B+ 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 177.89% 87% B+ 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 18.43% 74% C 78% C+
Dividend Return 18.43% 74% C 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 26.40% 91% A- 67% D+
Risk Adjusted Return 69.82% 98% N/A 88% B+
Market Capitalization 21.38B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Biotechnology) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 31.94 20% 30%
Price/Book Ratio 5.83 24% 19%
Price / Cash Flow Ratio 35.86 3% 8%
Price/Free Cash Flow Ratio 20.00 3% 13%
Management Effectiveness  
Return on Equity 24.38% 98% 92%
Return on Invested Capital 18.99% 90% 87%
Return on Assets 12.82% 99% 97%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.